WO2014075388A1 - 组织修复用纤维膜及其制品和制备方法 - Google Patents
组织修复用纤维膜及其制品和制备方法 Download PDFInfo
- Publication number
- WO2014075388A1 WO2014075388A1 PCT/CN2013/001387 CN2013001387W WO2014075388A1 WO 2014075388 A1 WO2014075388 A1 WO 2014075388A1 CN 2013001387 W CN2013001387 W CN 2013001387W WO 2014075388 A1 WO2014075388 A1 WO 2014075388A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- fiber
- layer
- tissue
- fibrous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/0045—Support slings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/07—Flat, e.g. panels
- B29C48/08—Flat, e.g. panels flexible, e.g. films
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0069—Electro-spinning characterised by the electro-spinning apparatus characterised by the spinning section, e.g. capillary tube, protrusion or pin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
- A61F2002/0068—Implantable repair or support meshes, e.g. hernia meshes having a special mesh pattern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/009—Special surfaces of prostheses, e.g. for improving ingrowth for hindering or preventing attachment of biological tissue
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/10—Polymers of propylene
- B29K2023/12—PP, i.e. polypropylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2027/00—Use of polyvinylhalogenides or derivatives thereof as moulding material
- B29K2027/12—Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
- B29K2027/16—PVDF, i.e. polyvinylidene fluoride
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2075/00—Use of PU, i.e. polyureas or polyurethanes or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/755—Membranes, diaphragms
Definitions
- Tissue repair fiber membrane product thereof and preparation method
- the fibrous membrane for tissue repair of the present invention can be free of living cell components, has sufficient material source, and has low cost, and avoids insufficient source of autologous, foreign body materials and animal-derived materials, and is simple to store and transport;
- Figure 3 is a scanning electron microscope comparison chart of the fibers of the fluffy fiber film A obtained in Example 4 and the fiber of the electrospun film B obtained in the step (2) of Example 4 at 5000x;
- Figure 5 is a diagram showing the repair effect of the PP group in the first month after the operation in Example 8.
- Figure 12 is a pathological view of the animal-derived group in Example 10 after 3 months;
- the fiber diameter in the present invention is determined by a scanning electron microscope method; the average pore diameter is measured by a bubble point method using a capillary flow pore size analyzer according to ASTM D 6767-2002; the tensile strength is It was measured by GB/T3923.1-1997 "Determination of Fabric Breaking Strength and Elongation at Break”; the thickness was measured by a compressive fabric style meter according to the method of GB 7689.1-2001.
- the method for producing a fibrous membrane for tissue repair according to the present invention includes a method using an electrospinning step.
- the receiving distance of the receiving device is adjusted to 5.0 to 30.0 cm, more preferably 15.0 to 20.0 cm.
- the transverse and longitudinal stretching rates are preferably each independently 50 to 400 mm/min, more preferably 50 mm/min to 200 mm/min.
- tissue repair of the present invention includes, but is not limited to, hernia repair, female pelvic floor dysfunction repair (including pelvic organ prolapse, bulging, and/or pelvic muscles such as uterus, vagina, rectum, urethra, bladder, etc.) Tissue relaxation recovery or hernia repair), use of artificial tissue (such as artificial rotator cuff, hard brain (ridge) membrane, skin, pericardium, blood vessels, nerve conduit, dental membrane, ligament, Achilles tendon, bone, etc.) Such as diaphragms, stents, etc.) Repair (fill) or restore structures to the tissue.
- hernia repair including pelvic organ prolapse, bulging, and/or pelvic muscles such as uterus, vagina, rectum, urethra, bladder, etc.
- Tissue relaxation recovery or hernia repair Tissue relaxation recovery or hernia repair
- artificial tissue such as artificial rotator cuff, hard brain (ridge) membrane, skin, pericardium, blood vessels
- the fibrous membrane for tissue repair of the present invention is used for manufacturing a hernia repair patch, a female pelvic floor dysfunction repair system (including a pelvic floor repair patch or a urinary incontinence sling or a sac patch), an artificial rotator cuff, Hard-brain (ridge) membrane repair patch, artificial skin, pericardial patch, artificial blood vessel, artificial nerve conduit, artificial tooth membrane, artificial ligament, artificial Achilles tendon, bone repair (filled) products, etc.
- the present invention further provides an article for tissue repair produced from the fibrous film for tissue repair.
- the material of the implanted membrane of the present invention includes a non-degradable material, a degradable material, or a combination thereof.
- the non-degradable materials mainly include polyfluorinated materials, such as polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), etc.; polyolefins such as polyethylene, polypropylene, etc.; polyurethane materials, such as polyurethane Acid ester (PU), polycarbonate polyurethane (PCU), polyether based polyurethane, silane modified polyurethane (SPU), and the like.
- PVDF polyvinylidene fluoride
- PTFE polytetrafluoroethylene
- polyolefins such as polyethylene, polypropylene, etc.
- polyurethane materials such as polyurethane Acid ester (PU), polycarbonate polyurethane (PCU), polyether based polyurethane, silane modified polyurethane (SPU), and
- polyethylene glycol polyethylene terephthalate, polymethyl methacrylate, polyhydroxybutyrate valerate, polyhydroxybutyrate caproate, polyphosphate, poly Carbamate, polyesteramide, polyvinyl alcohol, polydioxanone, polycarbonate, alginic acid, chondroitin sulfate, heparin, dextran, alginic acid, and the like.
- the implanted membrane of the present invention may be further subjected to post-treatment modification, for example, by one or more of a pore-forming treatment, a temperature elevation treatment, and a immersion treatment.
- the fibrous film can also be sewn with a wire or a polymer fiber.
- the use of a certain size of staggered holes or a combination of different sizes of holes can better facilitate tissue ingrowth, improve the internal and external exchange of substances, and facilitate the rapid elimination of metabolites during tissue and cell growth.
- the pores provide more space for tissue growth, which is more conducive to the penetration of capillaries.
- An implantable medical device made of the implanted patch of the present invention can be used for the treatment of female pelvic floor dysfunction.
- the tension-free urinary incontinence suspension strap of the present invention can be used for the treatment of female urinary incontinence, and the pelvic floor patch can be used for repairing prolapse and bulging of the pelvic organ.
- the bulky fibrous layer ( ⁇ ') of the anti-adhesion tissue repairing membrane of the present invention can be produced by the same method as the fibrous membrane for tissue repairing of the present invention.
- the fibrous material of the fluffy fibrous layer ( ⁇ ') and the intermediate layer of the present invention includes a non-degradable material, a degradable material, or Its combination.
- the non-degradable materials mainly include polyfluorinated materials, such as polyvinylidene fluoride (PVDF), polytetrafluoroethylene (PTFE), etc.; polyolefins, such as polyethylene, polypropylene, etc.; polyurethane materials, such as polyurethane. Acid ester (PU), polycarbonate polyurethane (PCU), polyether based polyurethane, silane modified polyurethane (SPU), and the like.
- PVDF polyvinylidene fluoride
- PTFE polytetrafluoroethylene
- polyolefins such as polyethylene, polypropylene, etc.
- polyurethane materials such as polyurethane.
- the spraying device for spraying the anti-adhesion layer ( ⁇ ') of the present invention is not particularly limited as long as it is sealed, and can pressurize the liquid filled therein to be pressurized from the spraying device.
- the nozzle is ejected.
- the above-mentioned multi-layered anti-adhesion tissue repairing film is preferably used for repairing abdominal wall hernia and incisional hernia.
- the design is mainly based on the following considerations: 1) The repair of the abdominal wall and the incisional hernia requires high mechanical strength. It is difficult to meet the requirements of ordinary simple electrospun membranes, so the braided mesh is added to ensure the mechanical strength. 2) The simple woven mesh is used for tamping repair, and the tissue to be repaired and grown cannot be well combined with the woven mesh, so that the woven mesh can not be fixed, and it is easy to form erosion and shrinkage. Therefore, a layer is added on both sides of the woven mesh.
- step (3) placing the polymer-wrapped woven mesh obtained in the step (2) in the middle of the two fiber membranes in the step (1), and then placing them on the ultrasonic welding machine under a certain ultrasonic power and pressure. , welding two fiber membranes on both sides of the woven mesh.
- the PVDF material was dissolved in a ⁇ , ⁇ -dimethylformamide/acetone mixed solvent having a volume ratio of 4:6 to make the concentration of PVDF in the solution 18 g/100 mL ; and a uniform fiber material solution was prepared.
- the fiber membrane obtained here has an average fiber diameter of 2 ⁇ m, a film thickness of 0.5 mm, and an average pore diameter of 115 ⁇ m.
- the tensile strength is 33 N/cm
- the bulkiness is 130 cm3/g
- the softness is 870 millinewtons.
- the fluffy fiber membranes prepared in Examples 1, 2, 3, 4, 5, and 6 were respectively laminated with a woven polypropylene (PP) (3DMAXTM Mesh sample supplied by the Second affiliated Hospital of Sun Yat-sen University). Then, using the 20,000 Hz frequency ultrasound (Futan Machinery Co., Ltd., model JT-200-S), the above layers were joined by point ultrasonic fusion every 10 cm distance to obtain the fibrous membrane for tissue repair and PP, respectively.
- Composite film of woven film 3DMAXTM Mesh sample supplied by the Second affiliated Hospital of Sun Yat-sen University.
- the PP group touched the surgical site and felt hard, and the presence of foreign matter was clearly felt.
- the PP group and the skin layer were unclear and could not be separated; the adhesion to the internal organs was severe; the microscopic observation showed that only a small amount of fibroblasts and collagen were formed around the patch, and a small amount of capillary proliferation ( ⁇ 5/HPF) was observed on the surface.
- ⁇ 5/HPF capillary proliferation
- vaginal and bladder specimens including pelvic floor repair implants were removed. Touch by hand, PVDF3 group,
- the PP material was the hardest, the PVDF4 material was the second, and the repaired parts were significantly different from the surrounding tissues.
- the PCU1 material was soft to the touch and the PVDF3 was the softest and tough.
- a large amount of fibroblasts and collagen were observed on the surface and inside of the PVDF3 patch, and the patch was integrated with the grown tissue, and the peeling could not be distinguished. Microscopic observation showed that the implanted patch area was tightly bound to collagen fibers and fibroblasts, and it was impossible to distinguish between new tissue and membrane material. A large amount of collagen fibers were visible inside, and the new tissue was completely integrated with the membrane to achieve regeneration. repair.
- the fibrous membrane for tissue repair prepared in Example 4, and the fibrous membrane obtained in the step (2) of Example 4 were cut into 4 cm x 6 cm, washed, and sterilized to prepare a PLLA1 dural repair patch (by Example 4).
- Example 4 prepared in tissue repair fiber membrane was cut into 5 C mx5cm, washing, sterilizing the artificial skin made of animal experiments.
- the experimental rabbits weighed 2-2.5kg, aged 6-8 months, male or female, a total of 12 rats. They were randomly divided into two groups (experimental group and control group), with 6 in each group. After the rabbit's ear vein anesthesia, the animals were placed on a dedicated operating table, and then the hair was prepared and disinfected. Use a scalpel to remove the full-thickness skin of the back: The resection area is 4*4cm. Then, the artificial dermis was attached: The experimental group was attached with artificial skin made of the fibrous film of Example 4 at the wound site, and fixed with sutures at intervals of 1 cm. The control group was treated as a blank control. The experimental group and the control group were covered with a layer of sterile oil yarn and sterile gauze, respectively, and fixed with sutures to the surrounding skin.
- the dermis layer appendage tube, sweat gland, hair follicle and other structures are visible. It can be seen that a large number of fibroblasts are arranged parallel to the surface of the skin, during which more capillaries proliferate and a small amount of lymphocytes infiltrate.
- the tissue repair fibrous membrane prepared in Example 2 was washed and sterilized to prepare a bone repair scaffold for rabbit animal experiments.
- the PVDF material was dissolved in a ⁇ , ⁇ -dimethylformamide/acetone mixed solvent having a volume ratio of 4:6 to make the concentration of PVDF in the solution 20 g/100 mL ; a uniform fibrous material solution was prepared.
- the fiber membrane obtained here had an average fiber diameter of 2 ⁇ m, a film thickness of 0.5 mm, an average pore diameter of 190 ⁇ m, a tensile strength of 43 N/cm, a bulkiness of 170 cm 3 /g, and a softness of 930 m Newton.
- the fluffy fiber layer (A2) prepared in Example 14 was covered on the surface of the receiving roller, and the PVDF solution was placed in an electrospinning syringe.
- the rate of the micro syringe pump was adjusted to 4 mL/hour, and the voltage of the high voltage generator was adjusted to 28 KV.
- the receiving distance of the receiving device is 20 cm
- the moving speed of the electrospinning needle is 10 cm/sec
- the receiving roller speed is 4000 lap/min
- electrospinning is performed
- the oriented fiber layer (B1) is formed on the fluffy fiber layer (A2).
- a two-layer fiber membrane comprising a bulky fibrous layer (A2) and an oriented fibrous layer (B1) is obtained.
- the PVDF material was dissolved in a ⁇ , ⁇ -dimethylformamide/acetone mixed solvent having a volume ratio of 4:6 to make the concentration of PVDF in the solution 20 g/100 mL ; a uniform fibrous material solution was prepared.
- thrombin lyophilized powder was made to have a concentration of 350 units/mL, and 1 mL of a thrombin solution was added to the above solution B to obtain a solution [.
- the diaphragm of the group was superior, and the surface of the diaphragm was covered with a layer of neoplastic epithelial tissue.
- the degree of vascularization was higher, and the membrane and the new tissue were not easily torn.
- the PVDF material of group IV was implanted 4 weeks later.
- the anatomical effect is shown in Fig. 20. It can be seen that there is no difference between the new tissue at the implantation site and the surrounding tissue.
- the pathological results showed that there were a large number of fibroblasts and collagen fibers on the surface and inside of the ⁇ - ⁇ group, and there were more capillaries (3-5/HPF) inside the patch. Among them, the V group was inside the patch. There are a large number of capillaries (5-10/HPF). It can be seen that the new tissue has grown into the inside of the membrane, the degree of vascularization is high, and the growth is faster, and the higher loft is more favorable for cell crawling, proliferation, and rapid growth of tissue. There are many fibroblasts and collagen fibers on the surface of the fiber membrane of the sputum group.
- the group I polypropylene mesh material still maintains considerable hardness compared with the 4th week after surgery, and has obvious foreign body sensation; the ⁇ group fiber membrane is soft, but the touch implant site and the surrounding tissue still exist.
- the difference between the softness of the ⁇ - ⁇ implanted membrane in the experimental group is basically close to that of the autologous tissue, and there is basically no obvious difference in the texture between the implanted material and the surrounding tissue; the touch of the V group material is almost consistent with the autologous tissue.
- the fiber membrane of group II can be peeled off from the new tissue, and more capillaries can be seen on the surface.
- the results under the microscope show that there are obvious boundaries between collagen fibers and fibroblasts around the group II fiber membrane, which is easy to distinguish between new tissue and membrane.
- the sheet material has a large amount of collagen fibers on the surface, and the capillaries are abundant. The material is still visible inside.
- the pathological results show that there are many fibroblasts on the surface of the material and a large number of capillaries grow (5-10/HPF), and a small amount of capillaries can be seen inside.
- Implantation method Prepare the rabbit's abdomen, disinfect, cut the abdominal skin along the midline, and bluntly separate the subcutaneous fascia and muscle, exposing the appropriate material implantation range. Three lcmx4 C m experimental group samples were implanted on the left side between the subcutaneous and fascia layers, and three lcmx4 C m control samples were implanted on the right side. The material was fixed in the corresponding position with a line 4, and the subcutaneous fascia layer and the skin layer were respectively sutured.
- the fibrous membrane for tissue repair prepared in Examples 1-3 was used as a bulky fibrous layer (A' l-3 ) of the anti-adhesion tissue repairing membrane.
- Example 23 The fibrous membrane for tissue repair prepared in Examples 1-3 was used as a bulky fibrous layer (A' l-3 ) of the anti-adhesion tissue repairing membrane.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Mechanical Engineering (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Textile Engineering (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Dermatology (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
- Laminated Bodies (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112015009502-0A BR112015009502B1 (pt) | 2012-11-14 | 2013-11-14 | Membrana fibrosa, membrana fibrosa compósita, método de preparação de membrana fibrosa, membrana implantável, método de preparação de membrana implantável, dispositivo médico implantável, mem brana fibrosa antiadesão, método de preparação de membrana fibrosa e uso de membrana fibrosa |
EP13854718.7A EP2921136B1 (en) | 2012-11-14 | 2013-11-14 | Fiber membranes for repairing tissue and products and preparation method thereof |
IN1362DEN2015 IN2015DN01362A (zh) | 2012-11-14 | 2013-11-14 | |
US14/377,665 US20160045296A1 (en) | 2012-11-14 | 2013-11-14 | Fiber membranes for repairing tissue and products and preparation method thereof |
KR1020157005750A KR101853283B1 (ko) | 2012-11-14 | 2013-11-14 | 조직 복구용 섬유막 및 그 제품 및 제조 방법 |
JP2015540990A JP6140295B2 (ja) | 2012-11-14 | 2013-11-14 | 組織修復用繊維膜及びその製品と製造方法 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210457158.2 | 2012-11-14 | ||
CN201210457521.0 | 2012-11-14 | ||
CN201210457158.2A CN103800096B (zh) | 2012-11-14 | 2012-11-14 | 骨盆底功能障碍性疾病修复用植入纤维膜片、制备方法及含有其的医疗器械 |
CN201210457521.0A CN103800097B (zh) | 2012-11-14 | 2012-11-14 | 一种组织修复用纤维膜及其制造方法和应用 |
CN201310372804.XA CN104414773B (zh) | 2013-08-23 | 2013-08-23 | 防粘连组织修复膜及其制备方法 |
CN201310372804.X | 2013-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014075388A1 true WO2014075388A1 (zh) | 2014-05-22 |
Family
ID=50730539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/001387 WO2014075388A1 (zh) | 2012-11-14 | 2013-11-14 | 组织修复用纤维膜及其制品和制备方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160045296A1 (zh) |
EP (1) | EP2921136B1 (zh) |
JP (1) | JP6140295B2 (zh) |
KR (1) | KR101853283B1 (zh) |
BR (1) | BR112015009502B1 (zh) |
IN (1) | IN2015DN01362A (zh) |
WO (1) | WO2014075388A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108772106A (zh) * | 2018-03-29 | 2018-11-09 | 天津工业大学 | 纤维增强型中空纳米纤维膜的制备方法及其功能化方法 |
CN112210891A (zh) * | 2020-09-30 | 2021-01-12 | 上海交通大学医学院附属上海儿童医学中心 | 一种载Axitinib的纳米纤维膜及其制备方法和在外科术后防粘连中的应用 |
CN112891638A (zh) * | 2021-01-18 | 2021-06-04 | 河南农业大学 | 一种具有抗菌作用的疝气补片的制备方法 |
CN113082299A (zh) * | 2021-03-18 | 2021-07-09 | 浙江农林大学 | 一种降解多孔pva/淀粉生物膜及其制备方法 |
CN114887119A (zh) * | 2022-05-09 | 2022-08-12 | 浙江大学医学院附属第一医院 | 一种具备抗感染能力的高分子人工硬脑膜及其制备方法 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106492274B (zh) * | 2015-11-27 | 2019-07-02 | 广州迈普再生医学科技股份有限公司 | 组织修复用纤维膜及其制备方法和应用以及组织修复用制品 |
CN106149203B (zh) * | 2016-07-22 | 2019-08-06 | 东华大学 | 一种载药纳米纤维膜及其应用 |
JP6772390B2 (ja) | 2017-03-06 | 2020-10-21 | ティーイーアイ バイオサイエンシズ,インコーポレイテッド | 穿孔された組織移植片 |
GB2564950A (en) * | 2017-06-08 | 2019-01-30 | Univ Sheffield | Scaffold |
GB201709173D0 (en) * | 2017-06-08 | 2017-07-26 | Univ Sheffield | Scaffold |
JP7050183B2 (ja) * | 2018-03-13 | 2022-04-07 | インスティテュート キミセ デ サリア セツ ファンダシオ プリバーダ | 血管修復パッチ |
GB201819609D0 (en) * | 2018-11-30 | 2019-01-16 | Univ Sheffield | Scaffold |
CN111803713A (zh) * | 2020-05-29 | 2020-10-23 | 广州新诚生物科技有限公司 | 一种编织膜、编织袋及编织方法 |
PL439682A1 (pl) | 2021-11-30 | 2023-06-05 | Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie | Sposób wytwarzania kurczliwej membrany ze skrobi i zastosowanie kurczliwej membrany ze skrobi w przemyśle spożywczym jako opakowanie |
PL439683A1 (pl) | 2021-11-30 | 2023-06-05 | Akademia Górniczo-Hutnicza Im.Stanisława Staszica W Krakowie | Sposób wytwarzania kurczliwej membrany ze skrobi i zastosowanie kurczliwej membrany ze skrobi w medycynie jako opatrunku |
CN114225121B (zh) * | 2021-12-22 | 2023-04-18 | 无锡中科光远生物材料有限公司 | 内皮化部分可吸收防粘连纤维膜及其制备方法 |
CN116236607A (zh) * | 2023-03-13 | 2023-06-09 | 华南理工大学 | 一种高强高释放的微纳米纤维素/海藻酸钠敷料及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008008266A2 (en) * | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
CN101507661A (zh) * | 2009-03-10 | 2009-08-19 | 广州迈普再生医学科技有限公司 | 一种具备多个功能层的纳米人工硬脑膜及其制备方法 |
CN101692986A (zh) * | 2009-03-10 | 2010-04-14 | 广州迈普再生医学科技有限公司 | 一种具有生物活性的人工硬脑膜及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007325543A (ja) * | 2006-06-08 | 2007-12-20 | Toray Ind Inc | 細胞足場材料およびその製造方法 |
BR112012000114A2 (pt) * | 2009-07-06 | 2016-11-01 | Coloplast As | arcabouço biodegradável para regeneração de tecido mole e uso do mesmo |
JP5718459B2 (ja) * | 2010-06-17 | 2015-05-13 | ワシントン・ユニバーシティWashington University | 整列した繊維を有する生物医学的パッチ |
-
2013
- 2013-11-14 EP EP13854718.7A patent/EP2921136B1/en active Active
- 2013-11-14 WO PCT/CN2013/001387 patent/WO2014075388A1/zh active Application Filing
- 2013-11-14 KR KR1020157005750A patent/KR101853283B1/ko active IP Right Grant
- 2013-11-14 IN IN1362DEN2015 patent/IN2015DN01362A/en unknown
- 2013-11-14 BR BR112015009502-0A patent/BR112015009502B1/pt active IP Right Grant
- 2013-11-14 US US14/377,665 patent/US20160045296A1/en not_active Abandoned
- 2013-11-14 JP JP2015540990A patent/JP6140295B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008008266A2 (en) * | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
CN101507661A (zh) * | 2009-03-10 | 2009-08-19 | 广州迈普再生医学科技有限公司 | 一种具备多个功能层的纳米人工硬脑膜及其制备方法 |
CN101692986A (zh) * | 2009-03-10 | 2010-04-14 | 广州迈普再生医学科技有限公司 | 一种具有生物活性的人工硬脑膜及其制备方法 |
Non-Patent Citations (3)
Title |
---|
LI, XINSONG ET AL.,: "NANO-POROUS ULTRA-HIGH SPECIFIC SURFACE ULTRAFINE FIBERS", CHINESE SCIENCE BULLETIN, vol. 49, no. 21, November 2004 (2004-11-01), pages 2160 - 2163, XP008178960 * |
See also references of EP2921136A4 * |
YAO, XIANG ET AL.,: "PREPARING BIODEGRADABLE POLYURETHANE POROUS SCAFFOLD FOR TISSUE ENGINEERING APPLICATION", PROGRESS IN CHEMISTRY, vol. 21, no. 7/8, 24 August 2009 (2009-08-24), pages 1546 - 1552, XP055248561 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108772106A (zh) * | 2018-03-29 | 2018-11-09 | 天津工业大学 | 纤维增强型中空纳米纤维膜的制备方法及其功能化方法 |
CN112210891A (zh) * | 2020-09-30 | 2021-01-12 | 上海交通大学医学院附属上海儿童医学中心 | 一种载Axitinib的纳米纤维膜及其制备方法和在外科术后防粘连中的应用 |
CN112891638A (zh) * | 2021-01-18 | 2021-06-04 | 河南农业大学 | 一种具有抗菌作用的疝气补片的制备方法 |
CN113082299A (zh) * | 2021-03-18 | 2021-07-09 | 浙江农林大学 | 一种降解多孔pva/淀粉生物膜及其制备方法 |
CN114887119A (zh) * | 2022-05-09 | 2022-08-12 | 浙江大学医学院附属第一医院 | 一种具备抗感染能力的高分子人工硬脑膜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
BR112015009502A2 (pt) | 2019-12-17 |
JP2016502426A (ja) | 2016-01-28 |
KR20150086227A (ko) | 2015-07-27 |
US20160045296A1 (en) | 2016-02-18 |
IN2015DN01362A (zh) | 2015-07-03 |
EP2921136A1 (en) | 2015-09-23 |
JP6140295B2 (ja) | 2017-05-31 |
KR101853283B1 (ko) | 2018-04-30 |
EP2921136B1 (en) | 2019-10-23 |
EP2921136A4 (en) | 2016-07-13 |
BR112015009502B1 (pt) | 2021-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014075388A1 (zh) | 组织修复用纤维膜及其制品和制备方法 | |
CN103800097B (zh) | 一种组织修复用纤维膜及其制造方法和应用 | |
CN103800096B (zh) | 骨盆底功能障碍性疾病修复用植入纤维膜片、制备方法及含有其的医疗器械 | |
US10058417B2 (en) | Absorbable implants for plastic surgery | |
ES2953544T3 (es) | Implante mamario de contorno completo | |
CN111840649B (zh) | 涂覆工艺制备的复合组织修复补片及其制备方法 | |
ES2768654T3 (es) | Implantes absorbibles para cirugía plástica | |
JP6297666B2 (ja) | 吸収性及び非吸収性材料の不規則に均一な三次元組織スカフォールド | |
WO2017088818A1 (zh) | 组织修复用纤维膜及其制备方法和应用以及组织修复用制品 | |
JP2021516294A (ja) | ポリ(ブチレンスクシネート)およびそのコポリマーを含む医用デバイス | |
RU2404819C2 (ru) | Тонкопленочная многоячеистая структура, изготовленная из коллагена, элемент для регенерации ткани, содержащий ее, и способ ее получения | |
JP2012511955A (ja) | 組織誘導再生のための生体適合性繊維系デバイス | |
JP6411445B2 (ja) | 吸収性及び非吸収性材料の不規則に均一な三次元組織スカフォールド | |
CN104414773A (zh) | 防粘连组织修复膜及其制备方法 | |
CN101773689B (zh) | 外科修复补片 | |
Yuan et al. | Application of synthetic and natural polymers in surgical mesh for pelvic floor reconstruction | |
JP2019503832A (ja) | 皮膚増強外科用縫合糸 | |
CN107756781A (zh) | 一种疝补片及其制备方法 | |
CN113350571B (zh) | 具有支撑层的复合人工纤维元及人工韧带 | |
Rajendran et al. | Contribution of textiles to medical and healthcare products and developing innovative medical devices | |
Kumar et al. | Carbon fibers in biomedical applications | |
MengQing et al. | Study on prevention of postoperative abdominal adhesions with PLGA nanofiber membrane | |
Ghosh et al. | 11 A Critique | |
CN117018283A (zh) | 以聚芳醚酮为基底的多层级纳米纤维人工硬脑膜及其制备方法 | |
CN115944790A (zh) | 腹壁补片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13854718 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015540990 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013854718 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20157005750 Country of ref document: KR Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015009502 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14377665 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 112015009502 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150428 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112015009502 Country of ref document: BR Kind code of ref document: A2 Free format text: APRESENTE TRADUCAO SIMPLES DAS CERTIDOES DE DEPOSITO DAS PRIORIDADES REIVINDICADAS OU DECLARACAO ASSINADA, AMBAS CONTENDO TODOS OS DADOS IDENTIFICADORES DAS PRIORIDADES, CONFORME ART. 16, 2O, DA LPI. |
|
ENP | Entry into the national phase |
Ref document number: 112015009502 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150428 |